These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1895970)

  • 1. Human immunodeficiency virus antibodies in sera of Australian blood donors: 1985-1990.
    Kaldor J; Whyte B; Archer G; Hay J; Keller A; Kennedy T; Mackenzie I; Pembrey R; Way B; Whyte G
    Med J Aust; 1991 Sep; 155(5):297-300. PubMed ID: 1895970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of blood donations for HIV-1 antibody: 1985-1991.
    Gunson HH; Rawlinson VI
    CDR (Lond Engl Rev); 1991 Dec; 1(13):R144-6. PubMed ID: 1669759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
    Bruhn R; Lelie N; Custer B; Busch M; Kleinman S;
    Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository.
    Kleinman SH; Niland JC; Azen SP; Operskalski EA; Barbosa LH; Chernoff AI; Edwards VM; Lenes BA; Marshall GJ; Nemo GJ
    Transfusion; 1989 Sep; 29(7):572-80. PubMed ID: 2672433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.
    MacDonald KL; Jackson JB; Bowman RJ; Polesky HF; Rhame FS; Balfour HH; Osterholm MT
    Ann Intern Med; 1989 Apr; 110(8):617-21. PubMed ID: 2648922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in human immunodeficiency virus seroprevalence in blood donors in northern Pakistan.
    Ghani E; Rathore MA; Khan SA
    Public Health; 2016 Feb; 131():71-4. PubMed ID: 26652710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic study of HIV serology in blood donors from 5 departments in northeastern France (1985-1989)].
    Aymard JP; Janot C; Contal P; Linel C; Monange G; Streiff F
    Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):421-9. PubMed ID: 2629757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious disease markers in blood donors in northern Thailand.
    Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
    Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety.
    Mapako T; Mvere DA; Chitiyo ME; Rusakaniko S; Postma MJ; van Hulst M
    Transfusion; 2013 Oct; 53(10 Pt 2):2413-21. PubMed ID: 23789991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
    Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
    AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
    Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
    Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
    Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
    Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city.
    Savarit D; De Cock KM; Schutz R; Konate S; Lackritz E; Bondurand A
    BMJ; 1992 Aug; 305(6852):498-502. PubMed ID: 1327367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group.
    Petersen LR; Doll LS
    Transfusion; 1991 Oct; 31(8):698-703. PubMed ID: 1926312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
    Whyte GS; Savoia HF
    Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.